Chemclin Diagnostics Co., Ltd. (SHA:688468)
China · Delayed Price · Currency is CNY 7.94
+0.08 (1.02%)
Feb 27, 2026, 3:00 PM CST
Chemclin Diagnostics Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 56.49 | 127.07 | 147.37 | 152.63 | 142.76 | 117.02 |
Depreciation & Amortization | 53.39 | 53.39 | 49.29 | 51.21 | 52.98 | 42.26 |
Other Amortization | 4.69 | 4.69 | 3.32 | 3.06 | 4.06 | 5.79 |
Loss (Gain) From Sale of Assets | -0.51 | -0.51 | -0.18 | -0.07 | 0.1 | 0.11 |
Asset Writedown & Restructuring Costs | 4.12 | 4.12 | 2.83 | 2.15 | 2.32 | 2.28 |
Loss (Gain) From Sale of Investments | -11.52 | -11.52 | -14.77 | -19.58 | -12.6 | -11.95 |
Provision & Write-off of Bad Debts | -0.2 | -0.2 | -0.41 | 0.02 | 0.14 | 0.29 |
Other Operating Activities | 14.29 | 7.86 | 1.22 | 1.97 | 1.22 | 0.3 |
Change in Accounts Receivable | 26.76 | 26.76 | 3.82 | 6.82 | 22.39 | 25.25 |
Change in Inventory | -1.34 | -1.34 | 1.12 | 7.95 | -25.15 | -14.07 |
Change in Accounts Payable | -31.44 | -31.44 | -11.55 | 26.11 | 4.6 | -19.6 |
Change in Other Net Operating Assets | - | - | - | 17.45 | - | 2.98 |
Operating Cash Flow | 103.79 | 167.95 | 173.05 | 244.56 | 188.86 | 151.95 |
Operating Cash Flow Growth | -43.65% | -2.95% | -29.24% | 29.49% | 24.29% | -24.50% |
Capital Expenditures | -70.11 | -107.49 | -301.37 | -125.28 | -72.55 | -83.31 |
Sale of Property, Plant & Equipment | 0.31 | 0.22 | 0.03 | 0.02 | 0.04 | 0.04 |
Investment in Securities | 168 | -39 | -22 | -10 | -252 | 49 |
Other Investing Activities | 10.51 | 12.21 | 15.66 | 20.76 | 13.97 | 12.06 |
Investing Cash Flow | 108.7 | -134.06 | -307.68 | -114.5 | -310.54 | -22.21 |
Long-Term Debt Issued | - | 23.71 | 196.48 | - | - | - |
Long-Term Debt Repaid | - | -8.12 | -13.33 | -11.78 | -11.09 | - |
Net Debt Issued (Repaid) | -18.12 | 15.59 | 183.16 | -11.78 | -11.09 | - |
Issuance of Common Stock | - | 0.85 | - | - | 261.35 | - |
Repurchase of Common Stock | -51.09 | -51.09 | - | - | - | - |
Common Dividends Paid | -57.48 | -53.28 | -139.15 | -68.17 | - | -107.01 |
Other Financing Activities | 48.2 | - | - | - | -8.26 | -4.18 |
Financing Cash Flow | -78.49 | -87.93 | 44.01 | -79.95 | 242 | -111.19 |
Foreign Exchange Rate Adjustments | 0.07 | 0.07 | 0.08 | 0.4 | -0.1 | -0.3 |
Net Cash Flow | 134.08 | -53.97 | -90.54 | 50.51 | 120.22 | 18.25 |
Free Cash Flow | 33.68 | 60.46 | -128.32 | 119.28 | 116.31 | 68.65 |
Free Cash Flow Growth | -1.31% | - | - | 2.55% | 69.43% | -52.99% |
Free Cash Flow Margin | 9.53% | 13.86% | -28.81% | 25.64% | 24.71% | 16.41% |
Free Cash Flow Per Share | 0.08 | 0.15 | -0.32 | 0.30 | 0.30 | 0.19 |
Cash Income Tax Paid | 41.05 | 69.87 | 96.57 | 62.9 | 62.44 | 49.93 |
Levered Free Cash Flow | -61.33 | 10.56 | -169.54 | 93.29 | 57.47 | 6.06 |
Unlevered Free Cash Flow | -56.89 | 13.84 | -169.25 | 93.61 | 57.93 | 6.06 |
Change in Working Capital | -16.95 | -16.95 | -15.62 | 53.18 | -2.12 | -4.14 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.